Indication

Brucellosis

Brucellosis is a systemic zoonotic bacterial infection caused by intracellular coccobacilli of the genus *Brucella*, primarily transmitted to humans through direct contact with infected livestock, occupational exposure, or the consumption of unpasteurized dairy products. Read more about Brucellosis

223 drugs 111 manufacturers

Advertisement

Drugs that treat it

Common Brucellosis therapies.

Showing 145–153 of 223 drugs

Filter & compare in the drug finder →Opens the drug finder with Brucellosis preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Brucellosis.

Brucellosis is a systemic zoonotic bacterial infection caused by intracellular coccobacilli of the genus *Brucella*, primarily transmitted to humans through direct contact with infected livestock, occupational exposure, or the consumption of unpasteurized dairy products.

The disease predominantly targets the reticuloendothelial system, though it can involve any organ system, including the musculoskeletal, hepatobiliary, nervous, and cardiovascular systems.

Clinically, it is characterized by an acute or insidious onset of undulant fever, profound fatigue, malaise, headache, drenching night sweats, and musculoskeletal manifestations such as arthralgia, sacroiliitis, or spondylitis.

Without prompt intervention, the organism can persist intracellularly within host macrophages, leading to chronic relapsing disease, focal abscesses, hepatosplenomegaly, or life-threatening infective endocarditis.

Personalize your experience

Follow Brucellosis and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it